Invention Grant
- Patent Title: Compounds as pharmaceutical agents
- Patent Title (中): 化合物作为药剂
-
Application No.: US10535381Application Date: 2003-11-24
-
Publication No.: US07405299B2Publication Date: 2008-07-29
- Inventor: Douglas Wade Beight , Timothy Paul Burkholder , Todd Vincent Decollo , Alexander Glenn Godfrey , Charles Raymond Heap , Chi-Hsin Richard King , Hong-Yu Li , William Thomas McMillen , Jason Scott Sawyer , Yan Wang , Clive Gideon Diefenbacher , Thomas Albert Engler , Sushant Malhotra , Sreenivasa Reedy Mundla
- Applicant: Douglas Wade Beight , Timothy Paul Burkholder , Todd Vincent Decollo , Alexander Glenn Godfrey , Charles Raymond Heap , Chi-Hsin Richard King , Hong-Yu Li , William Thomas McMillen , Jason Scott Sawyer , Yan Wang , Clive Gideon Diefenbacher , Thomas Albert Engler , Sushant Malhotra , Sreenivasa Reedy Mundla
- Applicant Address: US IN Indianapolis
- Assignee: Eli Lilly and Company
- Current Assignee: Eli Lilly and Company
- Current Assignee Address: US IN Indianapolis
- Agent Danica Hostettler; Tina M. Tucker
- International Application: PCT/US03/35969 WO 20031124
- International Announcement: WO2004/050659 WO 20040617
- Main IPC: C07D241/36
- IPC: C07D241/36 ; C07D217/00 ; C07D401/00
Abstract:
The current invention relates to compounds of the formula: (Ia) and the pharmaceutically acceptable salts thereof and their use as TGF-beta signal transduction inhibitors for treating cancer and other diseases in a patient in need thereof by administration of said compounds.
Public/Granted literature
- US20060058295A1 Novel compounds as pharmaceutical agents Public/Granted day:2006-03-16
Information query
